Skip to main content
. 2021 Nov 8;30:09636897211057077. doi: 10.1177/09636897211057077

Figure 4.

Figure 4.

The OS of LAHS patients who achieved lymphoma-CR (LAHS-CR) after chemotherapy (median OS time is 11.7 months [95% CI 0, 27.5]) was significantly better than those who didn’t (11.7 months [95% CI 0, 27.5] vs 2.1 months [95% CI 1.4, 2.9], P<0.001), but LAHS patients who underwent AHSCT still have a better prognosis than LAHS-CR patients (P=0.037).